Abstract 2120P
Background
Malnutrition is frequent, but underdiagnosed consequence of gastrectomy. Nutritional status is an important factor influencing optimal recovery after treatment. The aim of the present study was to assess the prevalence of micronutrient deficiencies post gastrectomies.
Methods
Between January 2022 and January 2023, 115 patients post gastrectomy had micronutrient screening including vitamin B12, vitamin D, folate, ferritin and albumin. Patients with any micronutrients deficiency were invited for a follow-up and rehabilitation (nutrient rich diet, supplements). Descriptive statistics and t-tests.
Results
Patients’ characteristics were as follow: 64.3% women and 35.6% men; median age 58 [30-81]; median follow-up period 19 months [2-24]; proportion of patients with deficiency in vitamin B12, vitamin D, folate, ferritin and albumin were 5.2%,40%,10.4%, 23.4% and 20.9%, respectively. We observed significant improvement in several indicators (vitamin B12 156→357mmol/l, vitamin D 24.6→69.4mmol/l, folate 2.7→9.6mmol/l, ferritin 16.4→92.2mmol/l, albumin 2.2→3.0mmol/l, p=0.01).
Conclusions
This study defined the prevalence of micronutrient deficiencies post gastrectomy. Appropriate nutritional intervention based on findings micronutrients deficiency led to improve quality of life.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2085P - Buprenorphine use and cancer outcomes
Presenter: Nosayaba Osazuwa-Peters
Session: Poster session 06
2086P - Management of opioids use disorder in cancer survivors
Presenter: Khalida Berkane
Session: Poster session 06
2087P - Impact of cancer pain on quality of life and financial well-being: A cross-sectional study on symptom management
Presenter: Raffaele Giusti
Session: Poster session 06
2088P - Management of cancer treatment-induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey among Italian oncologists
Presenter: Anna Amela Valsecchi
Session: Poster session 06
2090P - Management of trastuzumab deruxtecan-related nausea and vomiting in real-world practice
Presenter: Luca Licata
Session: Poster session 06
2091P - Dermocosmetics in management of cancer-related skin toxicities: International expert consensus highlighting the key role of oncology nurses
Presenter: Pascale Dielenseger
Session: Poster session 06
2092P - Bone loss in premenopausal Algerian women treated with chemotherapy for early-stage of breast cancer: Evaluation by DXA and identification of associated risk factors
Presenter: MACHEROUM Fatma zohra
Session: Poster session 06
2093P - Bioelectrical Impedance phase angle and obesity as a prognostic indicator in metastatic gastric cancer patients receiving second-line chemotherapy
Presenter: SangUk Han
Session: Poster session 06
2094P - A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant and olanzapine for highly emetogenic chemotherapy in breast cancer
Presenter: Shinya Takada
Session: Poster session 06